OpenEvidence, a company known for its AI-powered clinical decision support tools, has published a paper in JAMA, according to a STAT Health Tech newsletter article by Mario Aguilar. The piece, published Oct. 20, 2026, is headlined around the paper leaving open questions.
However, the full article is behind STAT+'s paywall, and the available text does not detail the paper's findings or the specific open questions. What is clear from the headline is that the publication in a prestigious journal does not settle all debate about the technology or the evidence.
Readers with access to STAT+ can read the full analysis. For now, the takeaway is that even a high-profile publication like JAMA may not provide complete answers about OpenEvidence's AI, and independent scrutiny continues.